Costlier dollar blamed
The prices of life-saving drugs are increasing seemingly due to costlier imports of raw materials and the depreciation of the taka vis-à-vis foreign currencies. Poor patients are the worst sufferers of this pricing disorder. Prices for most of the pharmaceutical products are on an upward trajectory, while drug traders blame manufacturing companies for the rise in the retail prices of almost all the
